A bill seeking to limit co-pays for prescription insulin advanced out of the House Health and Human Resources Committee Thursday.
After advancing several rules bundles, the committee took up the bill in its Thursday afternoon meeting. The bill, which originated in the House Health Committee, caps the cost of a 30-day supply of insulin at $25. However, the cost of supplies are not included in that cap.
Colorado was the first state to cap insulin co-pays, limiting costs to $100 a month, according to the Denver Post. Staff counsel told the committee that Virginia is weighing a similar measure to cap insulin co-pays at $30.
The bill now heads to the House Banking and Insurance Committee.
